Dr. Robert Joseph Settipane , MD
Allergy & Immunology • Warwick, RI
40 Toll Gate Rd
Warwick, RI 028864444
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Robert Settipane is listed in NPPES under Allergy & Immunology.
-
NPI assigned on November 21, 2006; this date does not establish years in practice.
-
Published CMS data list 3,731 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 95004 — Test for allergy using allergenic extract: 1,816 service units.
- 95165 — Professional service for preparation and provision of 1 or more antigens: 772 service units.
- 95117 — Professional service for multiple injections of allergen: 392 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,825 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 300 prescription fills, including refills.
- Fluticasone Propionate — 220 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) — 191 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 2,882 in 2020 to 3,731 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
40 Toll Gate Rd
Warwick, RI 028864444
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in East Providence, RI. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Allergy And Asthma Center Of Providence. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
New York University School Of Medicine
1985
What Public CMS Data Show
Allergy & Immunology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
224 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $59,900 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $42,545 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,016 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$583,592 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,625.45 across 104 records.
By nature of payment
- Food and Beverage: $2,529.79 across 102 records.
- Education: $95.66 across 2 records.
Reporting-company totals (3 largest of 16)
- AstraZeneca Pharmaceuticals LP: $684.84 across 29 records.
- Regeneron Pharmaceuticals, Inc.: $524.33 across 20 records.
- GlaxoSmithKline, LLC.: $444.38 across 16 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
41 years (graduated 1985)
CMS Doctors and Clinicians data list 1985 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Settipane has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Settipane as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Warwick and Rhode Island
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Not enough clinicians listed under Allergy & Immunology in Rhode Island have Medicare Part B data for 2024 to make a comparison.
Medicare-allowed amount
Not enough clinicians listed under Allergy & Immunology in Rhode Island have Medicare Part B data for 2024 to make a comparison.
Paid by Medicare
Not enough clinicians listed under Allergy & Immunology in Rhode Island have Medicare Part B data for 2024 to make a comparison.
Medicare Part D prescriptions
Not enough clinicians listed under Allergy & Immunology in Rhode Island have Medicare Part D data for 2024 to make a comparison.
Part D drug cost
Not enough clinicians listed under Allergy & Immunology in Rhode Island have Medicare Part D data for 2024 to make a comparison.
2 active clinicians are listed under Allergy & Immunology with a practice address in Warwick, RI (12 in Rhode Island).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 29% from 2,882 in 2020 to 3,731 in 2024.
- 2020: 2,882
- 2021: 3,403
- 2022: 4,298
- 2023: 3,514
- 2024: 3,731
-
Medicare-allowed amount
Medicare-allowed amount increased 24% from $48,436 in 2020 to $59,900 in 2024.
- 2020: $48,436
- 2021: $61,201
- 2022: $68,637
- 2023: $59,835
- 2024: $59,900
-
Paid by Medicare
Paid by Medicare increased 22% from $34,757 in 2020 to $42,545 in 2024.
- 2020: $34,757
- 2021: $44,682
- 2022: $49,053
- 2023: $43,725
- 2024: $42,545
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 23% from 1,484 in 2020 to 1,825 in 2024.
- 2020: 1,484
- 2021: 1,382
- 2022: 1,471
- 2023: 1,681
- 2024: 1,825
-
30-day fills
30-day fills increased 33% from 2,274 in 2020 to 3,016 in 2024.
- 2020: 2,274
- 2021: 2,174
- 2022: 2,373
- 2023: 2,718
- 2024: 3,016
-
Part D drug cost
Part D drug cost increased 134% from $249,589 in 2020 to $583,592 in 2024.
- 2020: $249,589
- 2021: $204,065
- 2022: $469,569
- 2023: $505,402
- 2024: $583,592
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 162% from $1,000.31 in 2021 to $2,625.45 in 2025.
- 2021: $1,000.31
- 2022: $1,673.49
- 2023: $2,270.36
- 2024: $2,089.98
- 2025: $2,625.45
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 104 records totaling $2,625.45.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $77.26 |
| Regeneron Pharmaceuticals, Inc. |
Education
In-kind items and services
|
DUPIXENT | General | $73.50 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.37 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $34.80 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $34.32 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.30 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $33.30 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $33.21 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $32.29 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $32.23 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $31.19 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.16 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $31.11 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $30.96 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $30.86 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $30.64 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.52 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.51 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $30.19 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $30.08 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $29.94 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $29.89 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.86 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $29.67 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $29.32 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
95004
Test for allergy using allergenic extract
|
1,816 | 43 | $10.10 | $3.57 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
772 | 28 | $23.00 | $14.87 |
|
95117
Professional service for multiple injections of allergen
|
392 | 35 | $25.00 | $12.51 |
|
95115
Professional service for single injection of allergen
|
182 | 16 | $21.00 | $10.47 |
|
95024
Test for allergy using allergenic extract injected into skin
|
178 | 28 | $12.39 | $7.63 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
178 | 133 | $136.64 | $90.73 |
|
94010
Test to measure expiratory airflow and volume
|
87 | 68 | $60.89 | $27.33 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
75 | 75 | $169.34 | $110.51 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
19 | 18 | $201.44 | $128.86 |
|
95076
Test for allergy using ingested items, initial 2 hours
|
17 | 17 | $183.34 | $117.30 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
15 | 15 | $256.89 | $167.45 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 300 | 20,835 | $3,832.69 | 82 |
| Fluticasone Propionate | Fluticasone Propionate | 220 | 14,408 | $4,935.77 | 80 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 191 | 5,467 | $6,874.59 | 55 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 106 | 3,900 | $80,541.07 | 19 |
| Azelastine Hcl | Azelastine Hcl | 99 | 6,568 | $3,307.85 | 37 |
| Ipratropium Bromide | Ipratropium Bromide | 87 | 4,037 | $3,695.20 | 34 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 81 | 3,033 | $11,456.83 | 17 |
| Dupixent Pen | Dupilumab | 58 | 1,736 | $248,361.75 | — |
| Ventolin Hfa | Albuterol Sulfate | 53 | 1,337 | $3,090.21 | 15 |
| Qvar Redihaler | Beclomethasone Dipropionate | 47 | 2,280 | $20,558.08 | 11 |
| Spiriva Respimat | Tiotropium Bromide | 44 | 1,680 | $28,567.03 | — |
| Prednisone | Prednisone | 42 | 362 | $111.64 | 26 |
| Arnuity Ellipta | Fluticasone Furoate | 41 | 1,890 | $12,871.40 | — |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 41 | 1,770 | $5,191.02 | 15 |
| Omeprazole | Omeprazole | 35 | 2,542 | $459.88 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 1,000 | $297.12 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | 1,680 | $21,610.97 | — |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 33 | 1,170 | $22,165.89 | — |
| Zafirlukast | Zafirlukast | 32 | 1,264 | $2,202.42 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 31 | 930 | $7,196.36 | — |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 31 | 1,050 | $8,464.04 | — |
| Dulera | Mometasone/Formoterol | 28 | 840 | $9,226.45 | — |
| Epinephrine | Epinephrine | 25 | 326 | $3,989.18 | 23 |
| Famotidine | Famotidine | 24 | 1,649 | $141.94 | — |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 20 | 1,242 | $312.19 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-06-09NUCC Taxonomy Code: 207K00000X
An allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20040203000617
RI
6608773882
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Allergy And Asthma Center Of Providence
450 Veterans Memorial Pkwy, East Providence, RI 029145300
Phone: 4013318426
Secondary Practice Locations
450 Veterans Memorial Pkwy Bldg 15a
East Providence, RI 029145300
Phone: 4013318426
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 40 TOLL GATE RD, WARWICK, RI 028864444 (Tel: 4017329191)
Registered at 40 TOLL GATE RD, WARWICK, RI 028864444 (Tel: 4017329191)
NPI status registered as active in NPPES database
Registered at 95 PITMAN STREET, PROVIDENCE, RI 02906 (Tel: 4013318426)
Registered at 95 PITMAN STREET, PROVIDENCE, RI 02906 (Tel: 4013318426)
Recorded as ROBERT SETTIPANE, MD
Allergy & Immunology (license number reported to NPPES: RI 7486)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
40 Toll Gate Rd
Warwick, RI 028864444
Phone: 4017329191